image
Avalo Therapeutics, Inc. AVTX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 12.41
-7.94 %
$ 129 M
Market Cap
0.13
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 -89.34% 24.28% 37.38%
Annual Report FY 10-K 2022-12-31 234.40% 50.61% 54.42%
Annual Report FY 10-K 2021-12-31 -19.42% -31.01% -204.73%
Annual Report FY 10-K 2020-12-31 -0.76% -295.70% -54.96%
Annual Report FY 10-K 2019-12-31 -63.17% 59.38% 55.76%
Annual Report FY 10-K 2018-12-31 -34.11% -337.43% -283.04%
Annual Report FY 10-K 2017-12-31 2312.24% 172.06% 186.38%
Annual Report FY 10-K 2016-12-31 0.00% -57.02% -46.05%
Annual Report FY 10-K 2015-12-31 0.00% 34.66% 35.67%
Annual Report FY 10-K 2014-12-31 0.00% -23.08% -32.33%
Annual Report FY 10-K 2013-12-31 0.00% -24.36% -23.29%
Annual Report FY 10-K 2012-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 5.51% 540.65% -242.96%
Quarterly Report Q2 8-K 2024-06-30 0.00% 1301.79% -32.48%
Quarterly Report Q1 8-K 2024-03-31 0.00% -1118.38% 40.53%
Quarterly Report Q4 8-K 2023-12-31 -36.27% 16.76% 55.14%
Quarterly Report Q3 8-K 2023-09-30 -98.42% -163.78% -117.30%
Quarterly Report Q2 8-K 2023-06-30 -37.75% 36.91% 39.55%
Quarterly Report Q1 8-K 2023-03-31 -59.51% 54.85% 57.84%
Quarterly Report Q4 8-K 2022-12-31 309.13% 48.89% 56.58%
Quarterly Report Q3 8-K 2022-09-30 1007.33% 118.35% 119.42%
Quarterly Report Q2 8-K 2022-06-30 -69.21% 24.07% 30.95%
Quarterly Report Q1 8-K 2022-03-31 147.99% 28.13% 31.81%
Quarterly Report Q4 8-K 2021-12-31 -85.36% -22.72% -24.83%
Quarterly Report Q3 8-K 2021-09-30 21.53% -29.25% -24.00%
Quarterly Report Q2 8-K 2021-06-30 150.79% -28.79% -44.98%
Quarterly Report Q1 8-K 2021-03-31 -82.82% -45.29% 2.65%
Quarterly Report Q4 8-K 2020-12-31 117.15% -964.97% -2833.85%
Quarterly Report Q3 8-K 2020-09-30 -80.21% -235.09% -257.34%
Quarterly Report Q2 8-K 2020-06-30 -69.93% -113.42% -97.71%
Quarterly Report Q1 8-K 2020-03-31 -49.11% -183.30% -347.30%
Quarterly Report Q4 8-K 2019-12-31 -175.03% 129.16% 109.85%
Quarterly Report Q3 8-K 2019-09-30 37.76% 83.68% 84.67%
Quarterly Report Q2 8-K 2019-06-30 -7.02% -3.59% -4.12%
Quarterly Report Q1 8-K 2019-03-31 20.72% -91.97% -101.12%
Quarterly Report Q4 8-K 2018-12-31 123.15% -79.81% -34.36%
Quarterly Report Q3 8-K 2018-09-30 -83.73% -131.43% -110.53%
Quarterly Report Q2 8-K 2018-06-30 2932.41% -234.02% -223.35%
Quarterly Report Q1 8-K 2018-03-31 1066.76% -98.04% -83.86%
Quarterly Report Q4 8-K 2017-12-31 1127.22% -88.63% -158.43%
Quarterly Report Q3 8-K 2017-09-30 7687.82% 403.48% 467.60%
Quarterly Report Q2 8-K 2017-06-30 -75.74% 48.97% 49.11%
Quarterly Report Q1 8-K 2017-03-31 0.00% 61.86% 61.57%
Quarterly Report Q4 8-K 2016-12-31 0.00% 55.07% 54.12%
Quarterly Report Q3 8-K 2016-09-30 0.00% -792.62% -204.40%
Quarterly Report Q2 8-K 2016-06-30 0.00% -20.99% -20.64%
Quarterly Report Q1 8-K 2016-03-31 0.00% -58.76% -98.97%
Quarterly Report Q4 8-K 2015-12-31 0.00% -44.57% 4.12%
Quarterly Report Q3 8-K 2015-09-30 0.00% 88.17% 67.34%
Quarterly Report Q2 8-K 2015-06-30 0.00% 28.33% 20.91%
Quarterly Report Q1 8-K 2015-03-31 0.00% 10.76% 31.55%
Quarterly Report Q4 8-K 2014-12-31 0.00% 17.95% -29.61%
Quarterly Report Q3 8-K 2014-09-30 0.00% -131.17% -136.97%
Quarterly Report Q2 8-K 2014-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2014-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2013-12-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2012-12-31 0.00% 0.00% 0.00%